Preexposure prophylaxis for the prevention of HIV transmission to women

AIDS

Volumn 27, Issue 1, 2013, Pages

  Aaron, Erika ^a   Cohan, Deborah ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Bay Area Perinatal AIDS Center   (United States)

Author keywords

discordant heterosexual couples; HIV prevention; HIV positive women; preexposure prophylaxis

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;

ARTICLE; CONCEPTION; DRUG EFFICACY; FEMALE; HETEROSEXUAL FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PREEXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; SEROCONVERSION; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

ADENINE; ANTI-HIV AGENTS; CHEMOPREVENTION; COST-BENEFIT ANALYSIS; DEOXYCYTIDINE; DIRECTIVE COUNSELING; FAMILY CHARACTERISTICS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; ORGANOPHOSPHONATES; PRIMARY HEALTH CARE; PRIMARY PREVENTION; REPRODUCTIVE BEHAVIOR; RISK-TAKING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84871613547     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835917b4     Document Type: Article

References (12)

1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 265:493-505.
2. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wanqisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012; 367:399-410.
3. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Seqolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367:423-434.
4. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S. The FEM-PrEP trial of emtricitabine/tenofovir disoproxil fumarate (Truvada) among African women. 19th CROI Conference March 2012; Seattle Washington.
5. Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A. Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 2001; 33:144-152; 165.
6. Lampe MA, Smith DK, Anderson GJ, Edwards AE, Nesheim SR. Achieving safe conception in HIV-discordant couples: the potential role of oral preexposure prophylaxis (PrEP) in the United States. Am J Obstet Gynecol 2011; 204:488. e1-488. e8.
7. Sauer MV. American physicians remain slow to embrace the reproductive needs of human immunodeficiency virus-infected patients. Fertil Steril 2006; 85:295-297; discussion 301. (Pubitemid 43170897)
8. Vernazza PL, Graf IM, Sonnenberg-Schwan U, Geit M, Meurer A. Preexposure prophylaxis and timed intercourse for HIVdiscordant couples willing to conceive a child. AIDS 2011; 25:2005-2008.
9. Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2011. Wilmington, NC: Registry Coordinating Center; 2011. http://www. APRegistry. com.
10. Curran K, Baeten J, Coates T, Kurth A, Mugo N, Celum C. HIV-1 prevention for HIV-1 serodiscordant couples. Curr HIV/AIDS Rep 2012; 9:160-170; doi: 10. 1007/s11904-012-0114-z.
11. Krummenacher I, Cavassini M, Bugnon O, Schneider MP. An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care 2011; 23:550-561.
12. Simoni JM, Pearson CR, Pantalone DW, Marks G, Crepaz N. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A metaanalytic review of randomized controlled trials. J Acquir Immune Defic Syndr 2006; 43 (Suppl 1):S23-35. (Pubitemid 44885639)